Skip to main content
Funding round brings in $25M for SPR Therapeutics

A round of Series C financing brought in $25 million for Cleveland-based medical device startup SPR Therapeutics. The proceeds will be used for commercializing the company's SPRINT Peripheral Nerve Stimulation system for chronic and acute pain, as well as to support additional studies exploring other indications for the technology.

Full Story: